An observational study in Myocardial Infarction, sponsored by State University of New York - Upstate Medical University. Completed at 1 site in United States. Open to participants aged 18 Years to 71 Years. Per ClinicalTrials.gov, last updated 2021-10-20.
Sponsored by State University of New York - Upstate Medical University · Observational
The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's planned enrollment of 100 is below the median of 500 across 983 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →State University of New York - Upstate Medical University is the lead sponsor of 154 studies on the registry; 17 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 4 (36%) have results posted.
Counted across the registry records on this site, refreshed daily.
Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG
Exclusion Criteria:
Perfusion abnormalities in nondiabetic and diabetic patients
Time frame: short term (3 month) and long term (12 month).
The effect of different glycemic control strategies on the reduction of coronary injury in diabetic and non-diabetic subjects
Time frame: short term (3 month) and long term (12 month)
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
State University of New York - Upstate Medical University